These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7640152)

  • 1. The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides.
    Wright JD; Helsby NA; Ward SA
    Br J Clin Pharmacol; 1995 Apr; 39(4):441-4. PubMed ID: 7640152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme.
    Helsby NA; Ward SA; Howells RE; Breckenridge AM
    Br J Clin Pharmacol; 1990 Aug; 30(2):287-91. PubMed ID: 2206791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.
    Birkett DJ; Rees D; Andersson T; Gonzalez FJ; Miners JO; Veronese ME
    Br J Clin Pharmacol; 1994 May; 37(5):413-20. PubMed ID: 8054246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
    Coller JK; Somogyi AA; Bochner F
    Br J Clin Pharmacol; 1999 Aug; 48(2):158-67. PubMed ID: 10417492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments.
    Funck-Brentano C; Becquemont L; Lenevu A; Roux A; Jaillon P; Beaune P
    J Pharmacol Exp Ther; 1997 Feb; 280(2):730-8. PubMed ID: 9023285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CYP2C19 in stereoselective hydroxylation of mephobarbital by human liver microsomes.
    Kobayashi K; Kogo M; Tani M; Shimada N; Ishizaki T; Numazawa S; Yoshida T; Yamamoto T; Kuroiwa Y; Chiba K
    Drug Metab Dispos; 2001 Jan; 29(1):36-40. PubMed ID: 11124227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine inhibits the CYP2C19-catalysed metabolism of proguanil in vitro.
    Rasmussen BB; Nielsen TL; Brøsen K
    Eur J Clin Pharmacol; 1998; 54(9-10):735-40. PubMed ID: 9923577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hydroxylation of omeprazole correlates with S-mephenytoin and proguanil metabolism.
    Kortunay S; Basci NE; Bozkurt A; Isimer A; Sayal A; Kayaalp SO
    Eur J Clin Pharmacol; 1997; 53(3-4):261-4. PubMed ID: 9476042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes.
    Hall SD; Guengerich FP; Branch RA; Wilkinson GR
    J Pharmacol Exp Ther; 1987 Jan; 240(1):216-22. PubMed ID: 2879902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6.
    Mankowski DC
    Drug Metab Dispos; 1999 Sep; 27(9):1024-8. PubMed ID: 10460802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro proguanil activation to cycloguanil is mediated by CYP2C19 and CYP3A4 in adult Chinese liver microsomes.
    Lu AH; Shu Y; Huang SL; Wang W; Ou-Yang DS; Zhou HH
    Acta Pharmacol Sin; 2000 Aug; 21(8):747-52. PubMed ID: 11501186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.
    Andersson T; Miners JO; Veronese ME; Birkett DJ
    Br J Clin Pharmacol; 1994 Aug; 38(2):131-7. PubMed ID: 7981013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.
    Wienkers LC; Wurden CJ; Storch E; Kunze KL; Rettie AE; Trager WF
    Drug Metab Dispos; 1996 May; 24(5):610-4. PubMed ID: 8723744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation.
    Chiba K; Saitoh A; Koyama E; Tani M; Hayashi M; Ishizaki T
    Br J Clin Pharmacol; 1994 Mar; 37(3):237-42. PubMed ID: 8198931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19.
    Suzuki H; Kneller MB; Haining RL; Trager WF; Rettie AE
    Drug Metab Dispos; 2002 Mar; 30(3):235-9. PubMed ID: 11854139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians.
    Skjelbo E; Mutabingwa TK; Bygbjerg Ib; Nielsen KK; Gram LF; Brøosen K
    Clin Pharmacol Ther; 1996 Mar; 59(3):304-11. PubMed ID: 8653993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes.
    Nakajima M; Inoue T; Shimada N; Tokudome S; Yamamoto T; Kuroiwa Y
    Drug Metab Dispos; 1998 Mar; 26(3):261-6. PubMed ID: 9492390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19.
    Zhang W; Ramamoorthy Y; Tyndale RF; Glick SD; Maisonneuve IM; Kuehne ME; Sellers EM
    Drug Metab Dispos; 2002 Jun; 30(6):663-9. PubMed ID: 12019193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype.
    Herrlin K; Massele AY; Rimoy G; Alm C; Rais M; Ericsson O; Bertilsson L; Gustafsson LL
    Clin Pharmacol Ther; 2000 Aug; 68(2):189-98. PubMed ID: 10976550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.